The Lancet Haematology in conversation with
The Lancet Group
Lan-Lan Smith, Editor-in-Chief of The Lancet Haematology, and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.
Episodes
Enrico Lopriore on haemolytic disease of the fetus and newbornNovember 29, 2023
Meletios Dimopoulos on relapsed and refractory multiple myelomaOctober 03, 2023
Eric Ohuma on haemoglobin concentrations and neonatal outcomesAugust 29, 2023
Margaret Ragni on tranexamic acid to treat heavy menstrual bleedingJuly 31, 2023
Oreofe Odejide and Thomas Kuczmarski on mental health and lymphomaJuly 03, 2023
Alok Srivastava on fitusiran for patients with haemophilia A and BMarch 29, 2023
Emmanuela E Ambrose on stroke prevention in children with sickle cell diseaseMarch 02, 2023
Sumit Gupta on racial and ethnic disparities in leukaemia survival outcomesJanuary 30, 2023
Xiao-Jun Huang on cellular therapy in ChinaNovember 28, 2022
Glenn Pierce on haemophilia care in LMICsAugust 30, 2022
Amy DeZern on the link between myelodysplastic syndrome and autoimmune disordersJune 30, 2022
Nicholas Crombie and Gavin Perkins on resuscitation with blood products compared with salineMarch 07, 2022
Fredrik Schjesvold on OCEAN phase 3January 31, 2022
Jacob D Soumerai and Andrew D Zelenetz on the BOVen regimen for previously untreated patients with chronic lymphocytic leukaemiaNovember 25, 2021
Raul Cordoba on haematological malignancies in older peopleNovember 03, 2021
Obiageli Nnodu and Dennis Chao on child mortality from sickle cell disease in NigeriaSeptember 21, 2021
Zuguo Mei and Gary Brittenham on iron deficiencyJuly 27, 2021
Eugenia Trigoso Arjona (in English) on nursing and haematological careMay 11, 2021
Eugenia Trigoso Arjona (in Spanish) on nursing and haematological careMay 11, 2021
Nada Hamad on inclusion and diversity in haematologyFebruary 23, 2021
Dr Judith Boer on lymphoblastic leukaemia in childrenDecember 22, 2020
Imatinib for paediatric leukaemiaDecember 15, 2018
Predicting the risk of adenoviraemiaAugust 31, 2018
Adverse events in haematological malignanciesJune 12, 2018
EPO blood doping and cycling: The Lancet Haematology: June 29, 2017June 30, 2017